参考文献:
[1] Shawn Shouye Wang. (2021), US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives, Antibody Therapeutics,vol 4,No.4.
[2] Chang, B. S. and Hershenson, S. (2002), Practical approaches to protein formulation development, in Rational Design of Stable Protein Formulations: Theory and Practice, Carpenter, J. F. and Manning, M. C., eds., Kluwer Academic/Plenum, New York, pp. 1–25.
[3] Jameel F, Hershenson S.15. High-Concentration Antibody Formulations[M]. John Wiley & Sons, Inc. 2010.